Sookjin Lee

Chief Business Officer (CBO) | Ph.D.

A business expert leading innovation in precision medicine and genomics for 20 years. Accelerating the commercialization of innovative technologies with academic expertise and market insight.

Cardiac genetic testing, Fabry disease: Interview with Dr. Geu Ru Hong2022. 08. 05
Comparing reanalysis policies of 5 rare disease diagnostics companies2022. 06. 23
The National Project of Bio Big Data (KDNA) Project in South Korea2022. 03. 31
The Importance of CAP Accreditation in Diagnostic Testing: 3billion’s Journey2022. 02. 09
Comparison of CNV analysis methods: Array CGH vs NGS2022. 01. 06
Reanalysis and reclassification, why are they important?2021. 12. 10